A joint-venture of U.S multinational firm Corning with SGD Pharma on Thursday began the construction of a pharmaceutical-glass-tubing facility at Mahabubnagar near Hyderabad.
The ₹500-crore project is likely to play a crucial role in increasing the primary packaging capabilities of the sector to support the increased vaccine and critical drug production in Telangana, Industries and IT Minister K.T. Rama Rao said following the ground-breaking ceremony.
SGD Corning Technologies, the joint-venture, will allow SGD Pharma to adopt Corning’s ‘Velocity Vial’ technology platform and expand pharmaceutical packaging manufacturing in India. The JV partners will help drug manufacturers respond to the increasingly complex capacity and quality issues and meet global demand for critical medicines, the companies said.
